Octagam 5%

intravenous immunoglobulin G (IVIG) 5% · Ocagamm (generic IVIG product implied); sponsor IMMUNOe Research Centers

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Octagam 5%, covering 2019-11-19 to 2019-11-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) [Phase 4]

See pricing